EUCTR2011-002816-97-GB进行中（未招募）不适用
A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects with Partly Controlled Atopic Asthma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Partially controlled atopic mild-moderate subjects with asthma
- •2. Receiving inhaled corticosteriods
- •3. Non-smoker or former smoker
- •4. Males and females aged 18 to 55 years inclusive
- •5. If female, must be of non-childbearing potential
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 36
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. History of acute severe asthma attacks
- •2. History of COPD
- •3. Other serious respiratory or other medical condition which may interfere with the outcome of the study
研究者
相似试验
已完成
不适用
A Randomized, Placebo-Controlled, Double-Blind, Parallel Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of LTI-291 in Patients with Parkinson*s Disease and a GBA1 MutatioGBA-Associated Parkinson's Diseasemovement disorder10028037NL-OMON44216ysosomal Therapeutics Incorperated40
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prevention of Episodic Cluster HeadacheEUCTR2012-003729-62-GBCENTER LABORATORIES, INC30
进行中（未招募）
1 期
Investigation of CRD007 in asthma patientsAsthmaEUCTR2015-002656-26-BGRSPR Pharma AB160
进行中（未招募）
1 期
Investigation of CRD007 in asthma patientsMedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2015-002656-26-DKRSPR Pharma AB160
进行中（未招募）
1 期
International study with many sites and where subjects are given CRD007 or placebo medication whereby site staff and subjects do not know which medication they are given. This study will collect data to show that the medication works as expected and is safe.AsthmaEUCTR2015-002656-26-GBRSPR Pharma AB168